INO Stock, Inovio Pharmaceuticals Inc. Information

The achievements of stimulating the immune system through vaccination have been profound. INO s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO s SynCon vaccines are designed to provide universal cross strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio s proprietary electroporation delivery, have been shown in humans to generate best in class immune responses with a favorable safety profile.